Patients and methods
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Radiotherapy and Oncology
- Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med. 2002; 347: 1233-1241
- Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med. 2002; 347: 1227-1232
- Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.J Clin Oncol. 2001; 19: 1688-1697
Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trial. Lancet 2005;366:17–25.
- Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801.Eur J Cancer. 1998; 34: 307-314
- Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.J Natl Cancer Inst. 2000; 92: 1143-1145
- Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control.Radiother Oncol. 1987; 8: 1-9
- Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.J Clin Oncol. 2007; 25: 3259-3265
- The Impact of tumor size and histology on local control after breast-conserving therapy.Radiother Oncol. 1988; 11: 297-303
- Advances in breast conservation therapy.J Clin Oncol. 2005; 23: 1685-1697
- Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer.Breast Cancer Res Treat. 2007; 105: 63-68
TNM – classification of malignant tumours. 4th ed. Fully Revised Edition; 1987. p. 95–6.
International commission of radiation units and measurements: dose specification for reporting external beam therapy with photons and electrons. Report 50. ICRU Publication: Bethesda, MD, USA, 1992.
- Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.N Engl J Med. 2001; 345: 1378-1387
- Quality assurance in the EORTC phase III randomised ‘boost vs. no boost’ trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.Radiother Oncol. 2005; 76: 278-284
- Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.Biometrics. 1975; 31: 103-115
- Nonparametric estimation from incomplete observations.J Am Stat Assoc. 1958; 53: 457-481
- A class of K-sample tests for comparing the cumulative incidence of a competing risk.Ann Stat. 1988; 16: 1141-1154
- Strahlenther Onkol. 2002; 178: 307-313
- Local control of operable breast cancer with radiotherapy only.Eur J Cancer. 1990; 26: 674-679
- The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma.Cancer. 1998; 82: 2212-2220
- Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.J Clin Oncol. 2000; 18: 1668-1675
- The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer.Int J Radiat Oncol Biol Phys. 1991; 21: 279-287
- Fifteen-year results of breast-conserving surgery and definitive irradiation for stage 1 and II breast carcinoma: The University of Pennsylvania Experience.Int J Radiat Oncol Biol Phys. 2004; 58: 233-240
Jones H, Antonini N, Colette L, et al. The impact of boost dose and margins on the local recurrence rate in breast conserving therapy: results from the EORTC Boost–No Boost Trial. Plenary oral presentation, 49th ASTRO-meeting. 28 October 2007–01 November 2007, Los Angeles. Int J Radiat Oncol Biol Phys 2007;69:abstract 2981.
- Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results.Radiother Oncol. 1989; 16: 253-267
- Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.Radiother Oncol. 2007; 82: 254-264
- Effect of age and radiation dose on local control after breast conserving treatment: EORTC Trial 22881-10882.Radiother Oncol. 2007; 82: 265-271
- Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?.Eur J Cancer. 2003; 39: 932-944
- The influence of the boost technique on local control in breast conserving treatment in the EORTC “boost versus no boost” randomised trial.Radiother Oncol. 2004; 72: 25-33
- High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization.Int J Radiat Oncol Biol Phys. 2006; 66: 923-930
- Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy.Int J Radiat Oncol Biol Phys. 2007; 68: 1018-1023